nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—ADRA1B—Signaling by GPCR—CCR2—atherosclerosis	0.000878	0.000878	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—EDNRA—atherosclerosis	0.000878	0.000878	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000875	0.000875	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CX3CR1—atherosclerosis	0.000864	0.000864	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CASR—atherosclerosis	0.000864	0.000864	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCL3—atherosclerosis	0.000862	0.000862	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000859	0.000859	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CCR2—atherosclerosis	0.000859	0.000859	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—GHRL—atherosclerosis	0.000855	0.000855	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CX3CL1—atherosclerosis	0.000847	0.000847	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CCL2—atherosclerosis	0.000843	0.000843	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—F2—atherosclerosis	0.00084	0.00084	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—EDN1—atherosclerosis	0.000839	0.000839	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL4—atherosclerosis	0.000839	0.000839	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—GHRL—atherosclerosis	0.000837	0.000837	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CCL5—atherosclerosis	0.000833	0.000833	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—KNG1—atherosclerosis	0.000827	0.000827	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AGTR1—atherosclerosis	0.000822	0.000822	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOA4—atherosclerosis	0.000809	0.000809	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000806	0.000806	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CNR2—atherosclerosis	0.000803	0.000803	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—CXCL8—atherosclerosis	0.000803	0.000803	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MMP3—atherosclerosis	0.000801	0.000801	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.0008	0.0008	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PRKCG—atherosclerosis	0.000792	0.000792	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOA2—atherosclerosis	0.000784	0.000784	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCR2—atherosclerosis	0.00078	0.00078	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—EDNRA—atherosclerosis	0.00078	0.00078	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000777	0.000777	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—EDN1—atherosclerosis	0.000762	0.000762	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—GHRL—atherosclerosis	0.00076	0.00076	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CCL5—atherosclerosis	0.000756	0.000756	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—KNG1—atherosclerosis	0.000751	0.000751	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CCL2—atherosclerosis	0.000749	0.000749	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—UTS2—atherosclerosis	0.000748	0.000748	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AGTR1—atherosclerosis	0.000746	0.000746	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL4—atherosclerosis	0.000746	0.000746	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—KNG1—atherosclerosis	0.000734	0.000734	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AGTR1—atherosclerosis	0.00073	0.00073	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PRKCG—atherosclerosis	0.000719	0.000719	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CX3CR1—atherosclerosis	0.000717	0.000717	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CASR—atherosclerosis	0.000717	0.000717	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VWF—atherosclerosis	0.000716	0.000716	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOC3—atherosclerosis	0.000712	0.000712	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LDLR—atherosclerosis	0.000707	0.000707	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CX3CL1—atherosclerosis	0.000703	0.000703	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AGT—atherosclerosis	0.000697	0.000697	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—EDN1—atherosclerosis	0.000697	0.000697	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOA2—atherosclerosis	0.000697	0.000697	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CCL5—atherosclerosis	0.000691	0.000691	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCL3—atherosclerosis	0.000691	0.000691	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—KNG1—atherosclerosis	0.000667	0.000667	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CNR2—atherosclerosis	0.000667	0.000667	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CXCL8—atherosclerosis	0.000666	0.000666	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MMP3—atherosclerosis	0.000665	0.000665	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—UTS2—atherosclerosis	0.000664	0.000664	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000664	0.000664	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AGTR1—atherosclerosis	0.000663	0.000663	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NCF1—atherosclerosis	0.000662	0.000662	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PRKCG—atherosclerosis	0.000657	0.000657	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—F2—atherosclerosis	0.000644	0.000644	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CASR—atherosclerosis	0.000637	0.000637	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000637	0.000637	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AGT—atherosclerosis	0.000633	0.000633	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—EDN1—atherosclerosis	0.000633	0.000633	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CCL5—atherosclerosis	0.000628	0.000628	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCR2—atherosclerosis	0.000625	0.000625	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EDNRA—atherosclerosis	0.000625	0.000625	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000625	0.000625	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CYBA—atherosclerosis	0.000622	0.000622	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—EDN1—atherosclerosis	0.000619	0.000619	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000616	0.000616	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	0.000614	0.000614	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PARP1—atherosclerosis	0.000609	0.000609	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GHRL—atherosclerosis	0.000609	0.000609	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PLAT—atherosclerosis	0.000609	0.000609	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PRKCG—atherosclerosis	0.000597	0.000597	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VWF—atherosclerosis	0.000594	0.000594	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	0.000592	0.000592	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	0.000592	0.000592	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	0.000591	0.000591	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOC3—atherosclerosis	0.000591	0.000591	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.00059	0.00059	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LDLR—atherosclerosis	0.000587	0.000587	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—F2—atherosclerosis	0.000585	0.000585	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000584	0.000584	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AGT—atherosclerosis	0.000578	0.000578	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL3—atherosclerosis	0.000573	0.000573	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	0.000562	0.000562	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CG—atherosclerosis	0.00056	0.00056	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	0.000558	0.000558	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NCF1—atherosclerosis	0.000549	0.000549	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—F2—atherosclerosis	0.000534	0.000534	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KNG1—atherosclerosis	0.000534	0.000534	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AGTR1—atherosclerosis	0.000531	0.000531	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	0.00053	0.00053	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VWF—atherosclerosis	0.000528	0.000528	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AGT—atherosclerosis	0.000525	0.000525	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	0.000525	0.000525	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	0.000521	0.000521	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CCL2—atherosclerosis	0.000521	0.000521	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCR2—atherosclerosis	0.000519	0.000519	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EDNRA—atherosclerosis	0.000519	0.000519	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PLG—atherosclerosis	0.000518	0.000518	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CYBA—atherosclerosis	0.000516	0.000516	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	0.000514	0.000514	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000511	0.000511	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	0.000509	0.000509	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PLAT—atherosclerosis	0.000505	0.000505	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PARP1—atherosclerosis	0.000505	0.000505	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GHRL—atherosclerosis	0.000505	0.000505	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SOCS3—atherosclerosis	0.00049	0.00049	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	0.000488	0.000488	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—F2—atherosclerosis	0.000485	0.000485	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	0.000475	0.000475	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MMP3—atherosclerosis	0.000473	0.000473	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF2—atherosclerosis	0.000471	0.000471	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	0.000467	0.000467	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	0.000464	0.000464	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	0.000461	0.000461	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	0.000461	0.000461	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	0.000459	0.000459	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOB—atherosclerosis	0.000458	0.000458	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000454	0.000454	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CXCL8—atherosclerosis	0.000454	0.000454	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EDN1—atherosclerosis	0.00045	0.00045	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	0.000449	0.000449	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	0.000449	0.000449	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	0.000449	0.000449	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCL5—atherosclerosis	0.000447	0.000447	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	0.000444	0.000444	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	0.000441	0.000441	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LPL—atherosclerosis	0.000437	0.000437	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	0.000433	0.000433	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—F2—atherosclerosis	0.000431	0.000431	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PLG—atherosclerosis	0.00043	0.00043	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRKCG—atherosclerosis	0.000425	0.000425	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SPP1—atherosclerosis	0.000414	0.000414	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000413	0.000413	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CXCL8—atherosclerosis	0.000412	0.000412	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	0.000407	0.000407	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.000394	0.000394	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	0.000393	0.000393	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.000392	0.000392	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	0.000391	0.000391	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000384	0.000384	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PDGFB—atherosclerosis	0.000383	0.000383	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.000382	0.000382	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOB—atherosclerosis	0.00038	0.00038	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	0.000377	0.000377	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AGT—atherosclerosis	0.000374	0.000374	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	0.000374	0.000374	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	0.000371	0.000371	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOE—atherosclerosis	0.000366	0.000366	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LEP—atherosclerosis	0.000366	0.000366	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CAV1—atherosclerosis	0.000363	0.000363	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LPL—atherosclerosis	0.000363	0.000363	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOA1—atherosclerosis	0.000362	0.000362	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	0.000361	0.000361	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	0.000353	0.000353	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ESR1—atherosclerosis	0.00035	0.00035	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.000349	0.000349	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.000348	0.000348	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—F2—atherosclerosis	0.000345	0.000345	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	0.000343	0.000343	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	0.000342	0.000342	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.000337	0.000337	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000334	0.000334	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000332	0.000332	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	0.000331	0.000331	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.000329	0.000329	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000322	0.000322	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	0.000318	0.000318	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	0.000317	0.000317	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	0.000313	0.000313	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—INS—atherosclerosis	0.000313	0.000313	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AGT—atherosclerosis	0.00031	0.00031	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	0.000308	0.000308	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	0.000305	0.000305	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOE—atherosclerosis	0.000304	0.000304	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LEP—atherosclerosis	0.000304	0.000304	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	0.000304	0.000304	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	0.000303	0.000303	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	0.000301	0.000301	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	0.000301	0.000301	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	0.00029	0.00029	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	0.000287	0.000287	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—F2—atherosclerosis	0.000287	0.000287	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	0.000282	0.000282	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	0.000276	0.000276	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	0.000274	0.000274	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	0.000274	0.000274	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	0.00027	0.00027	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	0.00027	0.00027	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	0.000268	0.000268	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	0.000267	0.000267	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	0.000263	0.000263	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—INS—atherosclerosis	0.00026	0.00026	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	0.000258	0.000258	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	0.000256	0.000256	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—F2—atherosclerosis	0.000255	0.000255	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	0.000251	0.000251	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000244	0.000244	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	0.000243	0.000243	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	0.000239	0.000239	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	0.000235	0.000235	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	0.000233	0.000233	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	0.000231	0.000231	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—INS—atherosclerosis	0.000231	0.000231	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	0.000228	0.000228	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	0.000227	0.000227	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	0.000223	0.000223	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	0.00022	0.00022	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	0.000218	0.000218	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	0.000214	0.000214	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	0.000214	0.000214	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	0.000212	0.000212	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	0.000202	0.000202	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	0.000202	0.000202	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	0.000198	0.000198	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	0.000196	0.000196	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	0.000195	0.000195	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	0.000192	0.000192	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	0.000187	0.000187	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	0.000183	0.000183	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	0.000181	0.000181	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	0.000181	0.000181	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	0.000179	0.000179	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	0.000178	0.000178	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	0.000177	0.000177	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	0.000173	0.000173	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	0.000171	0.000171	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	0.000164	0.000164	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	0.000162	0.000162	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	0.000162	0.000162	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	0.000161	0.000161	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	0.000158	0.000158	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	0.000157	0.000157	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	0.000155	0.000155	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	0.000151	0.000151	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	0.000146	0.000146	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	0.000144	0.000144	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	0.000138	0.000138	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—atherosclerosis	0.000137	0.000137	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	0.000134	0.000134	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	0.000126	0.000126	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	0.000105	0.000105	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	0.000101	0.000101	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	9.3e-05	9.3e-05	CbGpPWpGaD
